Health Care Professionals Knowledge, Attitudes, and Practice (KAP) Survey

Health Care Professionals – Help our research by completing the KAP survey. The purpose of this survey is to establish an understanding of the knowledge and attitudes of health care professionals about cannabis.

Study Overview

The Rheumatology Pain, Education, Attitudes, and Cannabis Experience (PEACE) Study is a concerted effort by a team of experts including clinicians, FORWARD, and the Canna Research Foundation. Our long-term goal is to understand the overall effectiveness of cannabis in patients with rheumatic and musculoskeletal diseases (RMDs).

The objective of this study is to evaluate the current use, experience, knowledge, and attitudes with cannabis among patients with RMDs and knowledge, attitudes, and practice among rheumatologists.

Legalization of cannabis use is rapidly increasing, as either a substitute for opioids or an adjunct treatment for chronic pain. Most patients with RMDs have chronic pain and reduced physical function, but epidemiological studies examining cannabis use in this population are lacking, leaving a gap in knowledge in patterns of use, effectiveness, tolerance, and overall safety. Furthermore, there are no recommendations on cannabis for rheumatologists to refer to, while patients are requesting information and may be self-medicating.

After this study creates a baseline understanding of the many facets of cannabis use, knowledge, and attitudes in rheumatology, we will be able to provide evidence-based recommendations to the rheumatology community and educational materials to rheumatologists and their patients on the guidance they seek but are currently lacking on cannabis.

  • Aim 1: To assess the knowledge, attitudes, and practice (KAP) of rheumatologists around cannabis use in their patient populations. We will survey all ACR members about their KAP.
  • Aim 2: To assess pain, education, attitudes, and cannabis experience (PEACE) in patients with RMDs. We will provide short surveys that measure KAP in cannabis and cannabis use for up to 1000 consecutive patients in each of 20+ rheumatology clinics throughout the US. In addition, we will conduct targeted surveys through established RMD patient registries, patient foundations, and social media for comparison.
Contact Us to Participate!

Key Personnel

Questions for us?


Other Personnel

  • Teresa Simon, MPH (Analyst)
  • Kristin Wipfler, PhD (Analyst)
  • Adam Cornish, PhD (IT)
  • Rebecca Schumacher (Administrator)

Study Timeline

Resources & Research Library

Medical Marijuana – Harvard Health Publishing

Learn About Cannabis – UCLA Cannabis Research Initiative

Cannabis and Cannabinoids: What You Need to Know – NIH (NCCIH)

Medical Marijuana Facts – MedicineNet

Survey of herbal cannabis (marijuana) use in rheumatology clinic attenders with a rheumatologist confirmed diagnosis
doi: 10.1097/j.pain.0000000000000706

Position statement: a pragmatic approach for medical cannabis and patients with rheumatic diseases
doi: 10.3899/jrheum.181120

Cannabis and cannabinoids in the treatment of rheumatic diseases
doi: 10.5041/RMMJ.10389

Adding medical cannabis to standard analgesic treatment for fibromyalgia: a prospective observational study
PMID: 32116208

An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia
doi: 10.1097/j.pain.0000000000001464

Cannabinoids for fibromyalgia pain: a critical review of recent studies (2015–2019)
doi: 10.1186/s42238-020-00024-2

Attitudes about cannabis mediate the relationship between cannabis knowledge and use in active adult athletes
doi: 10.1186/s42238-020-00023-3

Ohio physician attitudes toward medical Cannabis and Ohio’s medical marijuana program
doi: 10.1186/s42238-020-00025-1

CBD – Help or Hype? (podcast) – KoopCast with Dr. Zeiger